Daewoong, “They first need to verify sources of Meditoxin. They have no concrete proof”
The conflict between Medytox, which has had difficulties in entering the U.S. market, and Daewoong Pharmaceutical is getting serious.
As getting an actual dismissal of a civil case that Medytox filed against Daewoong Pharmaceutical on the last 19th in the U.S. with a ruling that ‘It would be app...
Fees
- Email service daily and homepage access.
- $300 per month. ($3,240 per year)
- 5 Email holders per each company.
- Anual contract base.
